V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270012765 | 270008298 | 0 | 98.5 | Curative (C) | 2015-10-26 | 2015-10-27 | COPP + Dacarbazine | 02 | N | 270012416 | COPP + DACARBAZINE |
| 270012766 | 270008299 | 1.75 | 34.8 | Curative (C) | 2016-02-06 | 2017-08-05 | CETUXIMAB | 2 | N | 270012423 | CETUXIMAB |
| 270012767 | 270008301 | 0 | 81 | Neo-adjuvant (N) | 2015-02-16 | 2015-03-11 | COPP + Dacarbazine | null | N | 270012431 | COPP + DACARBAZINE |
| 270012768 | 270008303 | 0 | 37.7 | Curative (C) | 2016-10-15 | 2016-10-15 | COPP + Dacarbazine | 02 | N | 270012434 | COPP + DACARBAZINE |
| 270012769 | 270008305 | 0 | 53.1 | Curative (C) | 2014-12-22 | 2015-01-04 | Trial Unspecified | Y | N | 270012436 | TRIAL |
| 270012770 | 270013940 | null | 46.5 | null | null | 2018-10-10 | Cetuximab 14 day | 2 | null | 270012438 | CETUXIMAB |
| 270012771 | 270008307 | 1.62 | 49.4 | Curative (C) | 2015-06-11 | 2015-07-05 | Trial Unspecified | N | null | 270012440 | TRIAL |
| 270012772 | 270008309 | 1.68 | 85 | Curative (C) | 2015-12-26 | 2015-12-26 | Cetuximab 7 day (Cycle 1) | N | null | 270012450 | CETUXIMAB |
| 270012773 | 270008310 | 1.65 | 59.4 | Curative (C) | 2016-02-27 | 2016-04-03 | HD EuroNet-PHL-C1 COPDAC | 1 | N | 270012458 | TRIAL |
| 270012774 | 270008311 | 0 | 76.5 | Curative (C) | 2014-12-15 | 2014-12-17 | COPP + Dacarbazine | 02 | N | 270012461 | COPP + DACARBAZINE |
| 270012775 | 270008314 | 1.53 | 60.6 | Curative (C) | 2015-03-07 | 2015-03-14 | Trial Unspecified | N | N | 270012461 | TRIAL |
| 270012776 | 270008315 | 1.81 | 66.4 | Curative (C) | 2016-04-04 | 2016-05-30 | Escalated BEACOPP | N | N | 270012463 | BEACOPP |
| 270012777 | 270008321 | null | 60.8 | Curative (C) | 2015-08-24 | 2016-05-24 | Cetuximab 7 day (Cycle 1) | 02 | N | 270012463 | CETUXIMAB |
| 270012778 | 270008321 | null | 55 | Curative (C) | 2014-07-07 | 2014-08-04 | COPP + Dacarbazine | N | N | 270012463 | COPP + DACARBAZINE |
| 270012779 | 270008322 | 1.79 | 93.8 | Curative (C) | 2014-07-05 | 2014-07-12 | BEACOPP-14 | 02 | N | 270012473 | BEACOPP |
| 270012780 | 270008323 | 0 | 71 | Curative (C) | 2015-09-23 | 2015-11-25 | COPP + Dacarbazine | N | null | 270012474 | COPP + DACARBAZINE |
| 270012781 | 270008325 | null | 82.6 | Curative (C) | 2013-05-18 | 2013-05-22 | Escalated BEACOPP | N | N | 270012475 | BEACOPP |
| 270012782 | 270008327 | 1.7 | 36.2 | Curative (C) | null | 2013-07-11 | Cetuximab 7 day (>Cycle 2) | N | null | 270012476 | CETUXIMAB |
| 270012783 | 270008327 | 1.64 | 64.3 | Curative (C) | 2014-01-31 | 2014-06-18 | Trial Unspecified | Y | null | 270012476 | TRIAL |
| 270012784 | 270008327 | 0 | null | Curative (C) | 2014-07-28 | 2014-08-05 | COPP + Dacarbazine | 02 | N | 270012476 | COPP + DACARBAZINE |
| 270012785 | 270008329 | 1.62 | 39.9 | Curative (C) | 2015-03-05 | 2015-03-19 | BEACOPP-14 | N | N | 270012492 | BEACOPP |
| 270012786 | 270008330 | 0 | null | Curative (C) | 2015-05-14 | 2015-05-14 | COPP + Dacarbazine | N | N | 270012501 | COPP + DACARBAZINE |
| 270012787 | 270008334 | null | 49 | Palliative (P) | null | 2016-02-29 | Cetuximab 7 day (>Cycle 2) | 2 | N | 270012502 | CETUXIMAB |
| 270012788 | 270013947 | 1.66 | 49.65 | Curative (C) | 2017-03-05 | 2017-03-17 | Cetuximab 14 day | N | N | 270012503 | CETUXIMAB |
| 270012789 | 270008337 | null | 64 | Curative (C) | 2017-04-03 | 2017-04-03 | BEACOPP-14 | 2 | N | 270012507 | BEACOPP |
| 270012790 | 270008337 | 1.68 | 61.2 | Curative (C) | 2015-03-09 | 2016-09-12 | CETUXIMAB | N | N | 270012507 | CETUXIMAB |
| 270012791 | 270008339 | 0 | 82.3 | Curative (C) | 2016-08-13 | 2016-08-13 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012510 | TRIAL |
| 270012792 | 270008339 | 1.64 | 67.9 | null | 2016-01-24 | 2016-05-16 | BEACOPP-14 | N | null | 270012510 | BEACOPP |
| 270012793 | 270008339 | null | 76.2 | Curative (C) | 2017-01-24 | 2017-01-24 | BEACOPP-14 | N | null | 270012510 | BEACOPP |
| 270012794 | 270008339 | 1.65 | null | Palliative (P) | 2013-11-15 | 2014-01-12 | Trial Unspecified | 01 | N | 270012510 | TRIAL |
| 270012795 | 270008340 | 1.78 | 55.4 | Curative (C) | 2015-06-21 | 2015-07-20 | Cetuximab 7 day (Cycle 1) | 2 | N | 270012523 | CETUXIMAB |
| 270012796 | 270008341 | null | 36.2 | Palliative (P) | null | 2014-01-24 | Cetuximab 14 day | N | N | 270012525 | CETUXIMAB |
| 270012797 | 270008346 | 1.85 | 77.3 | Curative (C) | 2016-05-14 | 2017-05-05 | HD EuroNet-PHL-C1 COPDAC | N | null | 270012526 | TRIAL |
| 270012798 | 270008346 | 0 | 50.1 | Curative (C) | 2017-08-10 | 2017-08-11 | COPP + Dacarbazine | N | null | 270012526 | COPP + DACARBAZINE |
| 270012799 | 270008347 | null | 59.5 | Curative (C) | 2016-06-23 | 2016-06-25 | COPP + Dacarbazine | N | N | 270012532 | COPP + DACARBAZINE |
| 270012800 | 270008348 | null | null | Curative (C) | 2013-06-15 | 2013-06-21 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012534 | TRIAL |
| 270012801 | 270013952 | 1.78 | 99.44 | Palliative (P) | 2015-10-09 | 2016-05-13 | Trial Unspecified | 01 | N | 270012536 | TRIAL |
| 270012802 | 270008350 | 1.8 | 77.3 | Curative (C) | 2015-03-28 | 2015-06-23 | BEACOPP-14 | N | Y | 270012536 | BEACOPP |
| 270012803 | 270018191 | 1.62 | 79.8 | Curative (C) | 2016-09-20 | 2016-09-20 | Cetuximab 7 day (>Cycle 2) | 99 | null | 270012539 | CETUXIMAB |
| 270012804 | 270008352 | 1.75 | 81 | Curative (C) | 2016-01-19 | 2016-01-19 | BEACOPP | 02 | N | 270012539 | BEACOPP |
| 270012805 | 270008353 | 1.76 | 85 | null | 2016-10-23 | 2016-12-03 | CETUXIMAB | N | N | 270012545 | CETUXIMAB |
| 270012806 | 270008355 | null | 59.9 | Curative (C) | 2014-09-11 | 2015-06-04 | Cetuximab 7 day (Cycle 1) | 02 | N | 270012548 | CETUXIMAB |
| 270012807 | 270008356 | 1.65 | 62.1 | Curative (C) | 2014-08-31 | 2015-01-06 | CETUXIMAB | null | N | 270012549 | CETUXIMAB |
| 270012808 | 270008357 | null | 62.1 | Curative (C) | 2017-04-27 | 2017-04-27 | Cetuximab 7 day (Cycle 1) | N | N | 270012555 | CETUXIMAB |
| 270012809 | 270013957 | 0 | 71.4 | Curative (C) | 2014-04-07 | 2014-06-05 | COPP + Dacarbazine | N | N | 270012556 | COPP + DACARBAZINE |
| 270012810 | 270008358 | 1.69 | 75.3 | Disease modification (D) | 2014-06-27 | 2014-09-02 | Trial Unspecified | 01 | N | 270012559 | TRIAL |
| 270012811 | 270008359 | 1.64 | null | Curative (C) | 2016-11-04 | 2017-01-08 | COPP + Dacarbazine | 2 | N | 270012559 | COPP + DACARBAZINE |
| 270012812 | 270008362 | 1.33 | null | Curative (C) | 2016-06-20 | 2016-06-25 | Trial Unspecified | null | null | 270012571 | TRIAL |
| 270012813 | 270008363 | 1.59 | 72 | Curative (C) | 2014-10-19 | 2014-10-28 | Cetuximab 14 day | 02 | N | 270012572 | CETUXIMAB |
| 270012814 | 270008363 | 1.78 | 17.05 | Curative (C) | 2015-06-28 | 2015-06-28 | Escalated BEACOPP | 02 | N | 270012572 | BEACOPP |